Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Fractyl Health, Inc. (GUTS : NSDQ)

• Company Description    Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including T2D and obesity. Fractyl Health is based in Lexington, MA. Number of Employees: 100

• Price / Volume Information    Yesterday's Closing Price: $0.91 Daily Weekly Monthly 20 Day Moving Average: 2,514,588 shares Shares Outstanding: 158.65 (millions) Market Capitalization: $144.31 (millions) Beta: 2.11 52 Week High: $3.03 52 Week Low: $0.38 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 56.56% 48.91% 12 Week 91.62% 77.14% Year To Date -58.65% -61.55%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3 VAN DE GRAAFF DRIVE SUITE 200 - BURLINGTON,MA 01803 USA ph: 781-902-8800 fax: - ir@fractyl.com http://www.fractyl.com

• General Corporate Information    Officers Harith Rajagopalan - Chief Executive Officer and Director Lara Smith Weber - Chief Financial Officer and Treasurer Kelly Barnes - Director William W. Bradley - Director Samuel Conaway - Director Peer Information Fractyl Health, Inc. (GSAC) Fractyl Health, Inc. (CASIF) Fractyl Health, Inc. (ALCD.) Fractyl Health, Inc. (OMNN) Fractyl Health, Inc. (CGPI.) Fractyl Health, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 35168W103 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/11/26 Share - Related Items Shares Outstanding: 158.65 Most Recent Split Date: (:1) Beta: 2.11 Market Capitalization: $144.31 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.15 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.60 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 35.03% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 6.75 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 73.47% vs. Previous Quarter: -186.67% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - -4,053.15 12/31/25 - - 09/30/25 - -2,896.77 ROA 03/31/26 - -96.41 12/31/25 - -104.24 09/30/25 - -105.72 Current Ratio 03/31/26 - 4.28 12/31/25 - 4.78 09/30/25 - 4.27 Quick Ratio 03/31/26 - 4.28 12/31/25 - 4.78 09/30/25 - 4.27 Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - -4,073,233.50 Book Value 03/31/26 - 0.13 12/31/25 - 0.07 09/30/25 - -0.02 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - 0.00 Debt-to-Equity 03/31/26 - 1.41 12/31/25 - 3.23 09/30/25 - - Debt-to-Capital 03/31/26 - 58.50 12/31/25 - 76.38 09/30/25 - -

Powered by Zacks Investment Research ©